The role of neoadjuvant chemotherapy in patients with advanced (stage IIIC) epithelial ovarian cancer

BACKGROUND: Primary treatment of patients with advanced epithelial ovarian cancer consists of chemotherapy either before (neoadjuvant chemotherapy, NACT) or after primary surgery (adjuvant chemotherapy). The goal of primary treatment is no residual disease after surgery (R0 resection) what is associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Škof, Erik, Merlo, Sebastjan, Pilko, Gasper, Kobal, Borut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024662/
https://www.ncbi.nlm.nih.gov/pubmed/27679552
http://dx.doi.org/10.1515/raon-2016-0034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024662/
https://www.ncbi.nlm.nih.gov/pubmed/27679552
http://dx.doi.org/10.1515/raon-2016-0034

Ejemplares similares